Abstract
DNA damaging agents have been widely used in cancer chemotherapy for many years and have proved successful in the treatment of both solid tissue and haematological malignancies. Many commonly used clinical agents, such as members of the nitrogen mustard, chloroethylnitrosourea, dimethane-sulphonate and platinum classes, are bifunctional. DNA interstrand crosslinks (ISC) formed in cells are clearly critical cytotoxic lesions and the formation of DNA ISC has been shown to correlate with cytotoxicity in vitro (1–5). Acquired resistance in vitro to such agents can occur by a number of mechanisms, for example altered drug transport (6), intracellular detoxification via enhanced glutathione and glutathione-S-transferase activity (7), but enhanced DNA repair capacity can also play an important role (3). Clinically the mechanisms of acquired resistance to DNA damaging agents are less clear but enhanced repair of ISC has been suggested to play a role in the acquired resistance of some cancers, e.g., chronic lymphocytic leukaemia to nitrogen mustards (8). In addition, the inherent sensitivity (and curability) of some tumors, e.g., testicular cancer, to DNA damaging agents may result in part from their inability to repair critical DNA lesions (9).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sunters, A., Springer, C. J., Bagshawe, K. D., Souhami, R. L., and Hartley, J. A. (1992) The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl) amino]benzoic acid. Biochem. Pharmacol. 44, 59–64.
O’Connor, P. M. and Kohn, K. W. (1990) Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Commun. 2, 387–394.
Zwelling, L. A., Michaels, S., Schwartz, H., Dobson, P. P., and Kohn, K. W. (1981) DNA crosslinking as an indicator of sensitivity and resistance of mouse L1210 leukaemia to cis-diamminedichloroplatinum (II) and L-phenylalanine mustard. Cancer Res. 41, 640–649.
Erickson, L. C., Laurent, G., Sharkey, N. A., and Kohn, K. W. (1980) DNA crosslinking and monoadduct repair in nitrosourea-treated human tumour cells. Nature 288, 727–729.
Bedford, P. and Fox, B. W. (1983) DNA-DNA interstrand crosslinking by dimethanesulphonic acid esters. Biochem. Pharmacol. 32, 2297–2301.
Rutman, R. J., Chun, E. H. L., and Lewis, F. S. (1968) Permeability difference as a source of resistance to alkylating agents in Ehrlich tumour cells. Biochem. Biophys. Res. Commun. 32, 650–657.
Yang, W. Z., Begleiter, A., Johnston, J. B., Israels L. G., and Mowat, M. R. A. (1992) Role of glutathione and glutathione S-transferase in chlorambucil resistance. Mol. Pharmacol. 41, 625–630.
Torres-Garcia, S. J., Cousineau, L., Caplan, S., and Panasci, L. (1989) Correlation of resistance to nitrogen mustards in chronic lymphocytic leukaemia with enhanced removal of melphalan-induced DNA crosslinks. Biochem. Pharmacol. 38, 3122–3123.
Koberle, B., Grimaldi, K. A., Sunters, A., Hartley, J. A., Kelland, L. R., and Masters, J. R. W. (1997) DNA repair capacity and cisplatin sensitivity of human testis tumour cells. Int. J. Cancer 70, 551–555.
Hartley, J. A., Berardini, M. D., and Souhami, R. L. (1991) An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and “second-arm” crosslink reactions. Anal. Biochem. 193, 131–134.
Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. (1981) Measurement of strand breaks and crosslinks by alkaline elution, in DNA Repair (Friedberg, E. C. and Hanawalt, P. C., eds.), Dekker, New York, pp. 379–408.
Ostling, O. and Johanson, K. J. (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Commun. 123, 291–298.
Fairbain, D. W., Olive, P. L., and O’Neill, K. L. (1995) The comet assay: a comprehensive review. Mutat. Res. 339, 37–59.
Tice R. R., Strauss, G. H., and Peters, W. P. (1992) High-dose combination alkylating agents with autologous bone marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutat. Res. 271, 101–113.
Hartmann, A. and Speit, G. (1994) Comparative investigations of the genotoxic effects of metals in the single cell gel (SCG) assay and the sister chromatid exchanges (SCE). Mutat. Res. 346, 49–56.
Olive, P. L., Wlodek, D., Durand, R. E., and Banath, J. P. (1992) Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp. Cell. Res. 198, 259–267.
Olive, P. L. and Banath, J. P. (1995) Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp. Cell. Res. 221, 19–26.
Pfuhler, S. and Wolf, H. W. (1996) Detection of DNA crosslinking with the alkaline comet assay. Environ. Mol. Mutagen. 27, 196–201.
Ward, T. H., Butler J., Shahbakhi, H., and Richards, J. T. (1997) Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells. Biochem. Pharmacol. 53, 1115–1121.
Olive, P. L., Banath, J. P., and Durand, R. E. (1990) Heterogeneity in radiation-induced DNA damage and repair in tumour and normal cells measured using the “comet” assay. Radiat. Res. 122, 86–94.
Klaude, M., Erikkson, S., Nygren, J., and Ahnstrom, G. (1996) The comet assay: mechanisms and technical considerations. Mutat. Res. 363, 89–96.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Spanswick, V.J., Hartley, J.M., Ward, T.H., Hartley, J.A. (1999). Measurement of Drug-Induced DNA Interstrand Crosslinking Using the Single-Cell Gel Electrophoresis (Comet) Assay. In: Brown, R., Böger-Brown, U. (eds) Cytotoxic Drug Resistance Mechanisms. Methods in Molecular Medicine™, vol 28. Humana Press. https://doi.org/10.1385/1-59259-687-8:143
Download citation
DOI: https://doi.org/10.1385/1-59259-687-8:143
Publisher Name: Humana Press
Print ISBN: 978-0-89603-603-1
Online ISBN: 978-1-59259-687-4
eBook Packages: Springer Protocols